Cargando…

Antiviral Drugs for Acute Infections

After the great success of the research and development of antiviral drugs to treat chronic infections like HIV and hepatitis C, attention is turning to treatment of acute viral infections. In this article, we illustrate the potential for developing antiviral drugs to treat such infections. Four dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, K.L., Thomas, E., Cockerill, G.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149606/
http://dx.doi.org/10.1016/B978-0-12-409547-2.12408-4
_version_ 1783520841984638976
author Powell, K.L.
Thomas, E.
Cockerill, G.S.
author_facet Powell, K.L.
Thomas, E.
Cockerill, G.S.
author_sort Powell, K.L.
collection PubMed
description After the great success of the research and development of antiviral drugs to treat chronic infections like HIV and hepatitis C, attention is turning to treatment of acute viral infections. In this article, we illustrate the potential for developing antiviral drugs to treat such infections. Four distinct clinical problems caused by four different viruses allow exploration of the problems associated with each disease. Targets for each virus are evaluated, and the progress made to date in identifying suitable clinical candidates is discussed. Finally, we consider the problem of emerging acute virus infections and improving rapidity of responses to them.
format Online
Article
Text
id pubmed-7149606
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-71496062020-04-13 Antiviral Drugs for Acute Infections Powell, K.L. Thomas, E. Cockerill, G.S. Comprehensive Medicinal Chemistry III Article After the great success of the research and development of antiviral drugs to treat chronic infections like HIV and hepatitis C, attention is turning to treatment of acute viral infections. In this article, we illustrate the potential for developing antiviral drugs to treat such infections. Four distinct clinical problems caused by four different viruses allow exploration of the problems associated with each disease. Targets for each virus are evaluated, and the progress made to date in identifying suitable clinical candidates is discussed. Finally, we consider the problem of emerging acute virus infections and improving rapidity of responses to them. 2017 2017-06-13 /pmc/articles/PMC7149606/ http://dx.doi.org/10.1016/B978-0-12-409547-2.12408-4 Text en Copyright © 2017 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Powell, K.L.
Thomas, E.
Cockerill, G.S.
Antiviral Drugs for Acute Infections
title Antiviral Drugs for Acute Infections
title_full Antiviral Drugs for Acute Infections
title_fullStr Antiviral Drugs for Acute Infections
title_full_unstemmed Antiviral Drugs for Acute Infections
title_short Antiviral Drugs for Acute Infections
title_sort antiviral drugs for acute infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149606/
http://dx.doi.org/10.1016/B978-0-12-409547-2.12408-4
work_keys_str_mv AT powellkl antiviraldrugsforacuteinfections
AT thomase antiviraldrugsforacuteinfections
AT cockerillgs antiviraldrugsforacuteinfections